Cochrane Abstracts
Erythromycin for the prevention and treatment of feeding intolerance in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Erythromycin for the Prevention and Treatment of Feeding Intolerance in Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435536/all/Erythromycin_for_the_prevention_and_treatment_of_feeding_intolerance_in_preterm_infants.
Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435536/all/Erythromycin_for_the_prevention_and_treatment_of_feeding_intolerance_in_preterm_infants. Accessed April 18, 2026.
Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435536/all/Erythromycin_for_the_prevention_and_treatment_of_feeding_intolerance_in_preterm_infants
Erythromycin for the Prevention and Treatment of Feeding Intolerance in Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435536/all/Erythromycin_for_the_prevention_and_treatment_of_feeding_intolerance_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Erythromycin for the prevention and treatment of feeding intolerance in preterm infants
ID - 435536
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435536/all/Erythromycin_for_the_prevention_and_treatment_of_feeding_intolerance_in_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
